A prospective randomized study to compare the efficacy of three different dose fractionation regimens in palliative radiotherapy for patients with painful bone metastasis.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 195
- 试验地点
- 1
- 主要终点
- Pain score assessment will be done among patients receiving 3 different treatment schedules during the course of treatment, at 1 month ,2 months and 3 months of follow up
研究概览
简要总结
AIM
To compare the efficacy of three different fractionation regimens like 8GY / single fraction , 20GY/ 5 fractions, 30GY/10 fractions with palliative radiotherapy for patients with symptomatic bone metastases
OBJECTIVES
PRIMARY OBECTIVE
1. To determine the duration of pain relief by using pain score
SECONDARY OBJECTIVE
1. To determine the analgesic requirement by using narcotic score
2. To determine the improvement in performance status by using ECOG
3. To determine improvement in quality of life by using BOMET-QOL questionnaire
MATERIALS AND METHODS:
**TYPE OF STUDY:**A prospective randomized control study
INCLUSION CRITERIA :
1. Radiologically evident bone metastases from any primary tumor site.
2. Patients with pain due to bone metastasis
3. Patients with uncomplicated bone pain
4. ECOG performance status 0-3
5. Patients who have given informed consent
6. Patients of age 18yrs or older
EXCLUSION CRITERIA:
1. Previous history of radioisotope treatment
2. Previous surgical intervention to same location
3. Patients with pathological fracture
4. Pregnant and lactating women
SELECTION OF PATIENT:
The study will be conducted on patients with bone metastasis who is satisfying inclusion criteria presenting to radiation oncology OPD at SVIMS Tirupati
STUDY PERIOD :
18 months from the date of IEC approval.
SAMPLE SIZE
The number of subjects required in ARM A, ARM B & ARM C was calculated to be 65 in each group . Hence total sample size is 195 subjects .
But the patients who satisfy inclusion criteria during the specified time period will only be included or atleast 30 patients in each arm as appropriate .
REGULATORY APPROVALS
The study has been approved by Institutional Thesis Protocol Approval Committee 9 roc No. AS/12/TPAC/SVIMS/2017)(TPAC No. 822, dated 25.04.24) and Institutional Ethics committee ( Roc No. AS /11/IEC/SVIMS/2017) dated 24.06.24. The study will be registered at Clinical Trial Registry India (CTRI)
INFORMED CONSENT:
A written informed consent will be obtained from all patients participating in the study.
RADIOTHERAPY TECHNIQUE:
After randomization patient immobilization will be done based on the location of bone metastasis.
Patients will undergo simulation on a SEIMENS CT (somatom definition AS, 80 cm bore size, Berlin, Munich-Germany) machine dedicated to radiotherapy treatment simulation in our institute.
CT images will be acquired in 3mm slice thickness and will be transferred to treatment planning system [Varian/Oncentra 4.3]
Planning will be done by 3DCRT technique
GTV, CTV, PTVand OARS will be contoured as per
GTV – clinically and radiologically identifiable bone lesions
CTV – GTV and areas harboring microscopic disease
PTV – CTV and a margin for set up errors and normal physiological movement of organs
Planning will be done on Oncentra/Eclipse treatment planning system such that PTV should get 95 -107% of total prescribed dose and normal tissue doses tolerance being respected.
Based on the randomization patients will receive 8Gy in single fraction or 20 Gy in 5 fractions or 30Gy in 10 fractions
EVALUATION OF PATIENT:
Patients will be evaluated for pain severity and frequency with pain score
Patients will also be evaluated for analgesic use before and after treatment
Pain assessmentand evaluation of analgesic usage will be done on the day of treatment, followed by daily during the course of treatment and then monthly after completion of RT for 3 months.
PAIN SCALE
Visual analogue scales (VAS)
The VAS is an unmarked line with extremes marked as no pain and worst pain.
Patients are asked to mark the point in the line that describes their pain.
Categorical verbal rating scales (VRS) -- 4 point scale
A VRS involves a sequence of words describing different intensity levels of pain
such as:
0-None
1-3 Mild
4-7 Moderate
8-10 Severe.
Evaluation of analgesic usage
Analgesic requirement was graded according to type of analgesic needed for pain relief, as:
0 = not requiring any analgesics;
1 = simple analgesics such as non-steroidal anti-inflammatory drugs (NSAIDS);
2 = mild narcotics (codeine, tramadol);
3 = strong narcotics (morphine, fentanyl);
4 = high dose narcotics inadequate.
Improvement in performance status was defined as a decrease in ECOG functional outcome score by at least one grade with respect to pre-treatment value.
STATISTICAL ANALYSIS
Study parameters data will be recorded on a predesigned study proforma and then entered in Microsoft office Excel and data studied by SPSS (26.0 V) version. Data will be summarised using number and percentage for qualitative +/- standard deviation.
- Association between any two categorical variables will be analysed using Chi square test.
- P value less than 0.05 indicates that there is an association between the two groups & the categorical variable.
- Statistically significant difference among the two groups with respect to any continuous variable will be analysed using sample T test.
· P value less than 0.05 indicates that there is a significant difference between the mean values among the two groups with respect to that variable
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant, Investigator and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Radiologically evident bone metastases from any primary tumor site.
- •2.Patients with pain due to bone metastasis 3.Patients with uncomplicated bone pain 4.ECOG performance status 0-3 5.Patients who have given informed consent 6.Patients of age 18yrs or older.
排除标准
- •1.Previous history of radioisotope treatment 2.Previous surgical intervention to same location 3.Patients with pathological fracture 4.Pregnant and lactating women.
结局指标
主要结局
Pain score assessment will be done among patients receiving 3 different treatment schedules during the course of treatment, at 1 month ,2 months and 3 months of follow up
时间窗: 1 month, 2 months, 3 months
次要结局
- 1.To determine the analgesic requirement by using narcotic score .
研究者
G Sindhu
Sri venkateswara institute of medical sciences tirupati
